308 related articles for article (PubMed ID: 32636931)
1. Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
Lycke J; Lenhoff S
Ther Adv Neurol Disord; 2020; 13():1756286420929467. PubMed ID: 32636931
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain G; Petrie J; Duffy KEM; Glover R; Hullock K; Papaioannou D; Roldan E; Beecher C; Bursnall M; Ciccarelli O; Coles AJ; Cooper C; Giovannoni G; Gabriel I; Kazmi M; Kyriakou C; Nicholas R; Paling D; Peniket A; Scolding N; Silber E; de Silva T; Venneri A; Walters SJ; Young C; Muraro PA; Sharrack B; Snowden JA;
BMJ Open; 2024 Feb; 14(2):e083582. PubMed ID: 38316583
[TBL] [Abstract][Full Text] [Related]
3. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
Bayas A; Berthele A; Blank N; Dreger P; Faissner S; Friese MA; Gerdes LA; Grauer OM; Häussler V; Heesen C; Janson D; Korporal-Kuhnke M; Kowarik M; Kröger N; Lünemann JD; Martin R; Meier U; Meuth S; Muraro P; Platten M; Schirmer L; Stürner KH; Stellmann JP; Scheid C; Bergh FT; Warnke C; Wildemann B; Ziemssen T
Ther Adv Neurol Disord; 2023; 16():17562864231180730. PubMed ID: 37780055
[TBL] [Abstract][Full Text] [Related]
4. Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis.
Mohammadi R; Aryan A; Omrani MD; Ghaderian SMH; Fazeli Z
Biologics; 2021; 15():53-59. PubMed ID: 33688164
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Bose G; Thebault S; Rush CA; Atkins HL; Freedman MS
Mult Scler; 2021 Feb; 27(2):167-173. PubMed ID: 32364422
[TBL] [Abstract][Full Text] [Related]
6. Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?
Mariottini A; Muraro PA; Saccardi R
Mult Scler Relat Disord; 2023 Oct; 78():104932. PubMed ID: 37572554
[TBL] [Abstract][Full Text] [Related]
7. Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT.
Kvistad SAS; Burman J; Lehmann AK; Tolf A; Zjukovskaja C; Melve GK; Bø L; Torkildsen Ø
J Neurol Neurosurg Psychiatry; 2022 Aug; 93(8):844-848. PubMed ID: 35508373
[TBL] [Abstract][Full Text] [Related]
8. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
Massey JC; Sutton IJ; Ma DDF; Moore JJ
Front Immunol; 2018; 9():410. PubMed ID: 29593711
[TBL] [Abstract][Full Text] [Related]
9. Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature.
Patti F; Chisari CG; Toscano S; Arena S; Finocchiaro C; Cimino V; Milone G
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207216
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Currò D; Mancardi G
Neurol Sci; 2016 Jun; 37(6):857-65. PubMed ID: 27071689
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis.
Mariottini A; Innocenti C; Forci B; Magnani E; Mechi C; Barilaro A; Nistri R; Fani A; Saccardi R; Massacesi L; Repice AM
Eur J Neurol; 2019 Apr; 26(4):624-630. PubMed ID: 30414315
[TBL] [Abstract][Full Text] [Related]
12. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
Harris KM; Lu T; Lim N; Turka LA
Front Immunol; 2018; 9():100. PubMed ID: 29456529
[TBL] [Abstract][Full Text] [Related]
13. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
[TBL] [Abstract][Full Text] [Related]
14. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Lachnit M; Revendova KZ; Hradilek P; Bunganic R; Koristek Z; Jelinek T; Skutova M; Piza R; Volny O; Hajek R; Bar M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):50-54. PubMed ID: 37337857
[TBL] [Abstract][Full Text] [Related]
15. Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
Mariottini A; Nozzoli C; Carli I; Landi F; Gigli V; Repice AM; Ipponi A; Cecchi M; Boncompagni R; Saccardi R; Massacesi L
Neurol Sci; 2024 Jan; ():. PubMed ID: 38277051
[TBL] [Abstract][Full Text] [Related]
16. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
17. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC; Clave E; Moins-Teisserenc H; Douay C; Farge D; Toubert A
Curr Res Transl Med; 2016; 64(2):107-13. PubMed ID: 27316394
[TBL] [Abstract][Full Text] [Related]
18. Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society.
Miller AE; Chitnis T; Cohen BA; Costello K; Sicotte NL; Stacom R;
JAMA Neurol; 2021 Feb; 78(2):241-246. PubMed ID: 33104165
[TBL] [Abstract][Full Text] [Related]
19. Does Resetting the Immune System Fix Multiple Sclerosis?
Bose G; Thebault SDX; Atkins HL; Freedman MS
Can J Neurol Sci; 2020 Jan; 47(1):1-10. PubMed ID: 31511117
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
